It may also lead to improved therapies to fight sleeping
sickness; current medications used to combat the
disease have improved
over the past decade but still include an old arsenic - based drug that kills between 5
and 10 percent of the people receiving treatment, said the study's senior author Stephen Hajduk, a professor of biochemistry
and molecular biology in the UGA Franklin College of Arts
and Sciences.